Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting—Results of a single centre pilot study

Abstract Background Excision of burn wounds is frequently associated with a large volume of blood loss requiring allogeneic blood transfusion. We conducted a pilot study to investigate the effect of activated recombinant coagulation factor VII (rFVIIa) on the reduction of blood transfusion requireme...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Burns 2007-06, Vol.33 (4), p.435-440
Hauptverfasser:	Johansson, Pär Ingemar, Eriksen, Kirsten, Nielsen, Søren Loumann, Rojkjaer, Rasmus, Alsbjørn, Bjarne
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antigens - blood Biological and medical sciences Blood transfusion Blood Transfusion - statistics & numerical data Burn Burns Burns - blood Burns - surgery Critical Care Enzyme-Linked Immunosorbent Assay Excision Factor VII - therapeutic use Factor VIIa Female Humans Interleukin-6 - metabolism International Normalized Ratio Intraoperative Care Male Medical sciences Middle Aged Pilot Projects Recombinant factor VII Recombinant Proteins - therapeutic use Skin grafting Skin Transplantation Traumas. Diseases due to physical agents Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!